John Nicholson, SVP & Chief Operating Officer at NEKTAR THERAPEUTICS (NKTR), sold 7,644 shares at $42.39 ($324K) on 2019-02-19, disclosed to the SEC on 2019-02-21.
Seasonal sale ($324k) by SVP & Chief Operating Officer — this insider has traded NKTR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.39 | 3,822 | $162K | 50.0% |
| 2 | $42.39 | 3,822 | $162K | 50.0% |
| Total | $42.39 avg | 7,644 | $324K | 100% |
| Filing → |
| NKTR | SELL | 2019-01-30 | $2.7M | — | Filing → |
| NKTR | SELL | 2018-11-19 | $458K | — | Filing → |
| NKTR | SELL | 2018-05-18 | $820K | — | Filing → |